(1)
Korman, N.; Passeron, T.; Gordon, K.; Okubo, Y.; Bagel, J.; Sofen, H.; Warren, R.; Bhatia, N.; Spelman, L.; Winthrop, K.; Hippeli, L.; Kisa, R.; Banerjee, S.; Thaçi, D. Deucravacitinib in Plaque Psoriasis: 2-Year Laboratory Results from the Phase 3 POETYK PSO Program. J of Skin 2022, 6, s46.